Clare J. Twist

Associate Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital

Professional Education

Internship: Children's Memorial Hospital (1988) IL

Residency: Children's Memorial Hospital (1990) IL

Fellowship: Children's Hospital Boston (1993) MA

Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1994)

Medical Education: Albany Medical Center (1987) NY

Fellowship, Children's Hospital, Boston/DFCI, Pediatric Hematology & Oncology (1993)

Residency, Children's Memorial Hospital, Pediatrics (1990)

M.D., Albany Medical College, Medicine (1987)

M.S., SUNY Buffalo, Immunology (1984)

B.S., University of Notre Dame, Pre-professional (1982)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
Liedtke, M., Twist, C. J., Medeiros, B. C., Gotlib, J. R., Berube, C., & Coutre, S. E. (2012). Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 97(1), 30-37.

Outcome for Children Treated for Relapsed or Refractory Acute Myelogenous Leukemia (rAML): A Therapeutic Advances in Childhood Leukemia (TACL) Consortium Study
Gorman, M. F., Ji, L., Ko, R. H., Barnette, P., Bostrom, B., & Loh, M. L. (2010). Outcome for Children Treated for Relapsed or Refractory Acute Myelogenous Leukemia (rAML): A Therapeutic Advances in Childhood Leukemia (TACL) Consortium Study. PEDIATRIC BLOOD & CANCER, 55(3), 421-429.

Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study
Ko, R. H., Ji, L., Barnette, P., Bostrom, B., Hutchinson, R., & Loh, M. L. (2010). Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study. JOURNAL OF CLINICAL ONCOLOGY, 28(4), 648-654.

Treatment of Recurrent Post-transplant Lymphoproliferative Disorder (PTLD) of the Central Nervous System (CNS) with High-dose Methotrexate (HD-MTX)
Twist, C. J., KJELSON, L., MCKENNEY, A., Bonham, C. A., Esquivel, C., & Castillo, R. O. (2009). Treatment of Recurrent Post-transplant Lymphoproliferative Disorder (PTLD) of the Central Nervous System (CNS) with High-dose Methotrexate (HD-MTX). XI INTERNATIONAL SMALL BOWEL TRANSPLANT SYMPOSIUM, 116-121.

Detection of Isolated Tumor Cells in Neuroblastoma by Immunohistochemical Analysis in Bone Marrow Biopsy Specimens Improved Detection With Use of beta-Catenin
Krishnan, C., Twist, C. J., Fu, T., & Arber, D. A. (2009). Detection of Isolated Tumor Cells in Neuroblastoma by Immunohistochemical Analysis in Bone Marrow Biopsy Specimens Improved Detection With Use of beta-Catenin. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(1), 49-57.

Precursor B-Cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis
O'Brien, M. M., Lee-Kim, Y., George, T. I., McClain, K. L., Twist, C. J., & Jeng, M. (2008). Precursor B-Cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis. PEDIATRIC BLOOD & CANCER, 50(2), 381-383.

I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma
Iagaru, A., Peterson, D., Quon, A., Dutta, S., Twist, C., & Albanese, C. (2008). I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma. MOLECULAR IMAGING AND BIOLOGY, 10(1), 19-23.

Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro
Bieber, M. M., Twist, C. J., Bhat, N. M., & Teng, N. Nh. (2007). Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro. PEDIATRIC BLOOD & CANCER, 48(4), 380-386.

A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: A study of the Children's Oncology Group
Osenga, K. L., Hank, J. A., Albertini, M. R., Gan, J., Sternberg, A. G., & Sondel, P. M. (2006). A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: A study of the Children's Oncology Group. CLINICAL CANCER RESEARCH, 12(6), 1750-1759.

The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives
London, W. B., Boni, L., Simon, T., Berthold, F., Twist, C., & De Bernardi, B. (2005). The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives. CANCER LETTERS, 228(1-2), 257-266.

Assessment of lymphadenopathy in children
Twist, C. J., & Link, M. P. (2002). Assessment of lymphadenopathy in children. PEDIATRIC CLINICS OF NORTH AMERICA, 49(5), 1009-?.

A case from Stanford University. Neuroblastoma with diffuse bone marrow involvement.
Durski, J. M., Twist, C. J., & Goris, M. (2001). A case from Stanford University. Neuroblastoma with diffuse bone marrow involvement. Nuclear medicine review. Central & Eastern Europe, 4(1), 61-62.

The mouse Cd83 gene: structure, domain organization, and chromosome localization
Twist, C. J., Beier, D. R., Disteche, C. M., Edelhoff, S., & Tedder, T. F. (1998). The mouse Cd83 gene: structure, domain organization, and chromosome localization. IMMUNOGENETICS, 48(6), 383-393.

Hurler syndrome: II. Outcome of HLA genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children
Peters, C., Shapiro, E. G., Anderson, J., Henslee-Downey, P. J., Klemperer, M. R., & Krivit, W. (1998). Hurler syndrome: II. Outcome of HLA genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. BLOOD, 91(7), 2601-2608.

ISOLATION OF MOUSE T-CELL LYMPHOMA LINES FROM DIFFERENT LONG-TERM INTERLEUKIN 2-DEPENDENT CULTURES
Giglia, J. S., OVAK, G. M., Yoshida, M. A., Twist, C. J., Jeffery, A. R., & Pauly, J. L. (1985). ISOLATION OF MOUSE T-CELL LYMPHOMA LINES FROM DIFFERENT LONG-TERM INTERLEUKIN 2-DEPENDENT CULTURES. CANCER RESEARCH, 45(10), 5027-5034.

STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .2. INITIATION OF PAIRED T-CELL AND B-CELL LINES FROM HEALTHY DONORS
Pauly, J., Russell, C. W., PIRELA, D. L., Twist, C. J., REINERTSON, R., & Minowada, J. (1983). STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .2. INITIATION OF PAIRED T-CELL AND B-CELL LINES FROM HEALTHY DONORS. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 172(3), 283-290.

STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .4. PRODUCTION OF SERUM-FREE AND MITOGEN-FREE SUPERNATANTS HAVING HIGH-LEVELS OF THE HUMAN T-CELL GROWTH-PROMOTER INTERLEUKIN-2
Pauly, J. L., Twist, C. J., PIRELA, D. L., REINERTSON, R. R., Callahan, J. J., & Russell, C. W. (1983). STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .4. PRODUCTION OF SERUM-FREE AND MITOGEN-FREE SUPERNATANTS HAVING HIGH-LEVELS OF THE HUMAN T-CELL GROWTH-PROMOTER INTERLEUKIN-2. IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 11(1), 77-78.

STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .6. CULTURE FLASK COMPOSITION MARKEDLY AFFECTS IL-2-DEPENDENT T-CELL PROLIFERATION AS DEFINED IN COMPARATIVE STUDIES OF GLASS, POLYSTYRENE AND POLYMETHYLPENTENE VESSELS
Pauly, J. L., OVAK, G. M., Twist, C. J., & RUSSEL, C. W. (1983). STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .6. CULTURE FLASK COMPOSITION MARKEDLY AFFECTS IL-2-DEPENDENT T-CELL PROLIFERATION AS DEFINED IN COMPARATIVE STUDIES OF GLASS, POLYSTYRENE AND POLYMETHYLPENTENE VESSELS. IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 11(6), 534-535.

STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .3. A QUANTITATIVE ASSAY OF THE HUMAN T-CELL GROWTH-PROMOTING LYMPHOKINE INTERLEUKIN-2
Pauly, J. L., Twist, C. J., PIRELA, D. L., REINERTSON, R. R., Callahan, J. J., & Russell, C. W. (1982). STUDIES OF CULTURED HUMAN LYMPHOCYTES-T .3. A QUANTITATIVE ASSAY OF THE HUMAN T-CELL GROWTH-PROMOTING LYMPHOKINE INTERLEUKIN-2. IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 10(11), 899-900.